查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1617715

血红素测试市场：按类型、技术、营运、应用、最终用户划分 - 2025-2030 年全球预测

Hemoglobin Testing Market by Type (Blood Glucose Testing, Cyanmethemoglobin Method, Hemoglobin Electrophoresis), Technology (Laboratory Testing, Point-of-Care Testing), Operation, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年血红素检测市场价值为57亿美元，预计2024年将达60.4亿美元，复合年增长率为6.10%，预计2030年将达到86.3亿美元。

血红素检测是医疗产业不可或缺的诊断程序，主要用于测量血液中血红素的含量、诊断贫血、监测糖尿病等慢性病的治疗效果。血红素检测的需求源于其在提供重要健康资讯和影响各个医学专业领域的病患管理决策方面的作用。其应用范围正从常规健康检查扩展到内科、小儿科、血液科等专业医疗机构，最终用途主要是医院、诊断实验室和居家医疗机构。影响血红素检测市场的关键成长要素包括血液疾病盛行率的增加、老年人口的增加以及就地检验技术的进步。此外，对个人化医疗的日益关注以及对医疗保健的认识和积极努力的提高等趋势也支持了市场的扩张。市场开拓机会包括开发非侵入性快速检测、与数位健康平台整合以提高资料可近性，以及扩展到医疗基础设施快速发展的新兴市场。然而，它们面临一些限制，例如与先进诊断设备相关的高成本以及全球在获得医疗服务方面的差异，这可能会阻碍它们的成长潜力。严格的监管要求也可能对新进入造成障碍。创新可以透过专注于测试程序的进步来推动，例如提高准确性、减少患者不适以及增强非专业环境下易于使用的应用程式。部署人工智慧和巨量资料分析来改善诊断见解和患者结果也可以带来显着的改善。总体而言，血红蛋白检测市场显示出动态成长潜力，但需要策略性地适应监管环境并投资于技术创新，以最大限度地利用机会。

主要市场统计
基准年[2023] 57亿美元
预测年份 [2024] 60.4亿美元
预测年份 [2030] 86.3亿美元
复合年增长率（%） 6.10%

市场动态：揭示快速发展的血红蛋白测试市场的关键市场洞察

供需的动态交互作用正在改变血红蛋白检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 慢性病的盛行率和定期血红素监测的必要性
    • 提供改进的、易于使用的就地检验
    • 政府努力提高贫血检测意识
  • 市场限制因素
    • 测试方法的复杂性和对专业技能的需求
  • 市场机会
    • 血红素检测方法的技术进步
    • 采用高性能家用血红素检测套组和设备
  • 市场问题
    • 对不准确和误报的担忧

波特五力：驾驭血红素测试市场的策略工具

波特的五力框架是了解血红素测试市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对血红素检测市场的影响

外部宏观环境因素在塑造血红蛋白检测市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解血红素检测市场的竞争格局

血红素测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：血红素检测市场供应商绩效评估

FPNV定位矩阵是评估血红素检测市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製血红素测试市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对血红蛋白测试市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病的盛行率和定期监测血红素浓度的必要性
      • 提供改进的使用者友善就地检验
      • 政府努力提高人们对贫血检测的认识
    • 抑制因素
      • 具体测试方法的复杂性和对专业技能的需求
    • 机会
      • 血红素检测方法的技术进步
      • 采用高性能家用套件和设备
    • 任务
      • 对不准确和误报的担忧
  • 市场区隔分析
    • 类型：使用氰化高铁血红蛋白方法作为测量总血红素浓度的标准且经济有效的技术
    • 操作：首选非侵入性血红素检测，因为它方便且减少与采血相关的不适
    • 应用：先进的血红蛋白测试解决方案，以确定贫血的严重程度
    • 最终用户：可以使用各种血红蛋白测试来诊断各种血液疾病
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 血红素检测市场：依类型

  • 介绍
  • 血糖值测试
  • 氰化高铁血红蛋白法
  • 血红素电泳

第七章 血红素检测市场：依技术分类

  • 介绍
  • 临床检查
  • 就地检验

第八章 血红素检测市场：依营运划分

  • 介绍
  • 侵入性测试
    • 侵入式比色皿
    • 侵入性剥离
  • 非侵入性测试

第九章血红素检测市场：依应用分类

  • 介绍
  • 贫血的诊断和监测
  • 糖尿病的诊断和治疗
  • 镰状细胞疾病筛检
  • 地中海贫血的检测

第 10 章 血红素测试市场：依最终使用者分类

  • 介绍
  • 血库
  • 诊断实验室
  • 居家医疗
  • 医院/诊所
  • 研究所

第十一章 北美和南美血红素检测市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区血红素检测市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章 欧洲、中东和非洲血红素检测市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Sanguina 的血红素检测套组获得美国FDA 批准
    • Mylab 推出独特的镰状贫血照护现场检测
    • Hemex Health 获得 300 万美元津贴，以推进瞪羚 Hb 突变测试在美国市场的商业化
  • 战略分析和建议

公司名单

  • Abcam PLC
  • ACON Laboratories, Inc.
  • AdvaCare Pharma
  • Arkray, Inc.
  • ARUP Laboratories
  • Attikouris Enterprises Ltd.
  • Avantor, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Boditech Med Inc.
  • Clarity Diagnostics, LLC
  • Cliawaived, Inc.
  • DiaSys Diagnostic Systems GmbH
  • EKF Diagnostics Holdings PLC by IBL PLC
  • F. Hoffmann-La Roche AG
  • HemoCue AB
  • Laboratory Corporation of America Holdings
  • Masimo Corp.
  • Merck KGaA
  • Nova Biomedical
  • OrSense Ltd.
  • PerkinElmer Inc.
  • Qiagen NV
  • Quest Diagnostics Incorporated
  • Siemens Healthcare GmbH
  • Sotera Health Company
  • Thermo Fisher Scientific Inc.
  • Versiti, Inc.
  • VivaChek BIoTech（Hangzhou）Co., Ltd.
Product Code: MRR-521BAA36EDBC

The Hemoglobin Testing Market was valued at USD 5.70 billion in 2023, expected to reach USD 6.04 billion in 2024, and is projected to grow at a CAGR of 6.10%, to USD 8.63 billion by 2030.

Hemoglobin testing is an essential diagnostic procedure within the healthcare industry, primarily used to measure the amount of hemoglobin in blood, diagnose anemia, and monitor treatment efficacy in chronic conditions like diabetes. The necessity for hemoglobin testing stems from its role in providing critical health information, influencing patient management decisions across various medical specialties. Applications extend from routine health check-ups to specialized care settings, spanning areas like internal medicine, pediatrics, and hematology, with end-use predominant among hospitals, diagnostic laboratories, and homecare settings. Key growth factors impacting the hemoglobin testing market include an increasing prevalence of blood disorders, growing geriatric population, and advances in point-of-care testing technology. Additionally, trends such as the heightened focus on personalized medicine, and the rise in awareness and proactive healthcare practices are propelling market expansion. Opportunities can be seized in the development of non-invasive and rapid testing methods, integration with digital health platforms for enhanced data accessibility, and expansion into emerging markets where healthcare infrastructure is evolving rapidly. However, the market faces limitations like high costs associated with advanced diagnostic equipment and varying access to healthcare services globally, which can stymie growth potential. Stringent regulatory requirements may also pose as barriers to market entry for new players. Innovation can be driven by focusing on advancements in testing procedures that improve accuracy, reduce patient discomfort, and enhance user-friendly applications for non-specialist environments. Embracing AI and big data analytics to improve diagnostic insights and patient outcomes can also lead to significant improvements. Overall, the hemoglobin testing market demonstrates dynamic growth potential, yet it necessitates strategic navigation through regulatory landscapes and investment in technological innovations to maximize opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 5.70 billion
Estimated Year [2024] USD 6.04 billion
Forecast Year [2030] USD 8.63 billion
CAGR (%) 6.10%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hemoglobin Testing Market

The Hemoglobin Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic diseases and need for regular hemoglobin level monitoring
    • Availability of improved and user-friendly point-of-care testing
    • Government initiatives promoting awareness about anemia testing
  • Market Restraints
    • Complexity of certain testing methods and need for specialized skills
  • Market Opportunities
    • Technological advancements in hemoglobin testing methods
    • Introduction of high-performing home hemoglobin testing kits and devices
  • Market Challenges
    • Concerns associated with inaccuracy and false positives

Porter's Five Forces: A Strategic Tool for Navigating the Hemoglobin Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hemoglobin Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hemoglobin Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hemoglobin Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hemoglobin Testing Market

A detailed market share analysis in the Hemoglobin Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hemoglobin Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hemoglobin Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hemoglobin Testing Market

A strategic analysis of the Hemoglobin Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hemoglobin Testing Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, ACON Laboratories, Inc., AdvaCare Pharma, Arkray, Inc., ARUP Laboratories, Attikouris Enterprises Ltd., Avantor, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Boditech Med Inc., Clarity Diagnostics, LLC, Cliawaived, Inc., DiaSys Diagnostic Systems GmbH, EKF Diagnostics Holdings PLC by IBL PLC, F. Hoffmann-La Roche AG, HemoCue AB, Laboratory Corporation of America Holdings, Masimo Corp., Merck KGaA, Nova Biomedical, OrSense Ltd., PerkinElmer Inc., Qiagen N.V., Quest Diagnostics Incorporated, Siemens Healthcare GmbH, Sotera Health Company, Thermo Fisher Scientific Inc., Versiti, Inc., and VivaChek Biotech (Hangzhou) Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Hemoglobin Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Blood Glucose Testing, Cyanmethemoglobin Method, and Hemoglobin Electrophoresis.
  • Based on Technology, market is studied across Laboratory Testing and Point-of-Care Testing.
  • Based on Operation, market is studied across Invasive Testing and Non-Invasive Testing. The Invasive Testing is further studied across Invasive Cuvette and Invasive Strip.
  • Based on Application, market is studied across Anemia Diagnosis & Monitoring, Diabetes Diagnosis & Management, Sickle Cell Disease Screening, and Thalassemia Detection.
  • Based on End-User, market is studied across Blood Bank, Diagnostic Laboratories, Homecare Settings, Hospitals & Clinics, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and need for regular hemoglobin level monitoring
      • 5.1.1.2. Availability of improved and user-friendly point-of-care testing
      • 5.1.1.3. Government initiatives promoting awareness about anemia testing
    • 5.1.2. Restraints
      • 5.1.2.1. Complexity of certain testing methods and need for specialized skills
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in hemoglobin testing methods
      • 5.1.3.2. Introduction of high-performing home hemoglobin testing kits and devices
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with inaccuracy and false positives
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Use of cyanmethemoglobin method as a standard and cost-effective technique for measuring total hemoglobin concentration
    • 5.2.2. Operation: Preference for non-invasive hemoglobin testing due to their convenience and ability to reduce discomfort associated with blood draws
    • 5.2.3. Application: Advanced hemoglobin testing solutions to determine the severity of anemia
    • 5.2.4. End-User: Availability of diverse range of hemoglobin testing to diagnose various hematological disorders
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hemoglobin Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Blood Glucose Testing
  • 6.3. Cyanmethemoglobin Method
  • 6.4. Hemoglobin Electrophoresis

7. Hemoglobin Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Laboratory Testing
  • 7.3. Point-of-Care Testing

8. Hemoglobin Testing Market, by Operation

  • 8.1. Introduction
  • 8.2. Invasive Testing
    • 8.2.1. Invasive Cuvette
    • 8.2.2. Invasive Strip
  • 8.3. Non-Invasive Testing

9. Hemoglobin Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Anemia Diagnosis & Monitoring
  • 9.3. Diabetes Diagnosis & Management
  • 9.4. Sickle Cell Disease Screening
  • 9.5. Thalassemia Detection

10. Hemoglobin Testing Market, by End-User

  • 10.1. Introduction
  • 10.2. Blood Bank
  • 10.3. Diagnostic Laboratories
  • 10.4. Homecare Settings
  • 10.5. Hospitals & Clinics
  • 10.6. Research Institutes

11. Americas Hemoglobin Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Hemoglobin Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Hemoglobin Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Sanguina Receives US FDA Clearance for Haemoglobin Test Kit
    • 14.3.2. Mylab Introduces Indigenous Point-of-Care Sickle Cell Anaemia Test
    • 14.3.3. Hemex Health Awarded USD 3 Million Grant to Advance Commercialization of Gazelle Hb Variant Test for the U.S. market
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. ACON Laboratories, Inc.
  • 3. AdvaCare Pharma
  • 4. Arkray, Inc.
  • 5. ARUP Laboratories
  • 6. Attikouris Enterprises Ltd.
  • 7. Avantor, Inc.
  • 8. Becton, Dickinson and Company
  • 9. Bio-Rad Laboratories, Inc.
  • 10. Bio-Techne Corporation
  • 11. Boditech Med Inc.
  • 12. Clarity Diagnostics, LLC
  • 13. Cliawaived, Inc.
  • 14. DiaSys Diagnostic Systems GmbH
  • 15. EKF Diagnostics Holdings PLC by IBL PLC
  • 16. F. Hoffmann-La Roche AG
  • 17. HemoCue AB
  • 18. Laboratory Corporation of America Holdings
  • 19. Masimo Corp.
  • 20. Merck KGaA
  • 21. Nova Biomedical
  • 22. OrSense Ltd.
  • 23. PerkinElmer Inc.
  • 24. Qiagen N.V.
  • 25. Quest Diagnostics Incorporated
  • 26. Siemens Healthcare GmbH
  • 27. Sotera Health Company
  • 28. Thermo Fisher Scientific Inc.
  • 29. Versiti, Inc.
  • 30. VivaChek Biotech (Hangzhou) Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. HEMOGLOBIN TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. HEMOGLOBIN TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEMOGLOBIN TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEMOGLOBIN TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY BLOOD GLUCOSE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY CYANMETHEMOGLOBIN METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY HEMOGLOBIN ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE CUVETTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE STRIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY NON-INVASIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY ANEMIA DIAGNOSIS & MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY DIABETES DIAGNOSIS & MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY SICKLE CELL DISEASE SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY THALASSEMIA DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 282. HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023